Funding

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Funder
National Institutes of Health
Opportunity type
Grant
Call status
Closed
Opens
2025-01-05
Deadline
2026-10-05
View opportunity

Overview

Supports investigator-led phase 0, I or II clinical trials of cancer diagnostic or therapeutic interventions within participating NCI programme interests. Phase III trials are excluded.

Funding amount

Up to USD 499,999 in direct costs per year

Eligibility

Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.

Additional deadlines

Next new-application deadline: 5 October 2026. Next renewal/resubmission/revision deadline, where permitted: 5 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 January 2027. This is separate from the application deadline.

Contact
National Institutes of Health ยท grantsinfo@nih.gov
Keywords
Health sciences
Official source
NIH / Grants.gov
Last checked
2026-09-19